Prostaglandin in the ventromedial hypothalamus regulates peripheral glucose metabolism. 2021

Ming-Liang Lee, and Hirokazu Matsunaga, and Yuki Sugiura, and Takahiro Hayasaka, and Izumi Yamamoto, and Taiga Ishimoto, and Daigo Imoto, and Makoto Suematsu, and Norifumi Iijima, and Kazuhiro Kimura, and Sabrina Diano, and Chitoku Toda
Laboratory of Biochemistry, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.

The hypothalamus plays a central role in monitoring and regulating systemic glucose metabolism. The brain is enriched with phospholipids containing poly-unsaturated fatty acids, which are biologically active in physiological regulation. Here, we show that intraperitoneal glucose injection induces changes in hypothalamic distribution and amounts of phospholipids, especially arachidonic-acid-containing phospholipids, that are then metabolized to produce prostaglandins. Knockdown of cytosolic phospholipase A2 (cPLA2), a key enzyme for generating arachidonic acid from phospholipids, in the hypothalamic ventromedial nucleus (VMH), lowers insulin sensitivity in muscles during regular chow diet (RCD) feeding. Conversely, the down-regulation of glucose metabolism by high fat diet (HFD) feeding is improved by knockdown of cPLA2 in the VMH through changing hepatic insulin sensitivity and hypothalamic inflammation. Our data suggest that cPLA2-mediated hypothalamic phospholipid metabolism is critical for controlling systemic glucose metabolism during RCD, while continuous activation of the same pathway to produce prostaglandins during HFD deteriorates glucose metabolism.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Ming-Liang Lee, and Hirokazu Matsunaga, and Yuki Sugiura, and Takahiro Hayasaka, and Izumi Yamamoto, and Taiga Ishimoto, and Daigo Imoto, and Makoto Suematsu, and Norifumi Iijima, and Kazuhiro Kimura, and Sabrina Diano, and Chitoku Toda
April 2019, Experimental & molecular medicine,
Ming-Liang Lee, and Hirokazu Matsunaga, and Yuki Sugiura, and Takahiro Hayasaka, and Izumi Yamamoto, and Taiga Ishimoto, and Daigo Imoto, and Makoto Suematsu, and Norifumi Iijima, and Kazuhiro Kimura, and Sabrina Diano, and Chitoku Toda
January 2010, Sensors (Basel, Switzerland),
Ming-Liang Lee, and Hirokazu Matsunaga, and Yuki Sugiura, and Takahiro Hayasaka, and Izumi Yamamoto, and Taiga Ishimoto, and Daigo Imoto, and Makoto Suematsu, and Norifumi Iijima, and Kazuhiro Kimura, and Sabrina Diano, and Chitoku Toda
July 2012, The Journal of clinical investigation,
Ming-Liang Lee, and Hirokazu Matsunaga, and Yuki Sugiura, and Takahiro Hayasaka, and Izumi Yamamoto, and Taiga Ishimoto, and Daigo Imoto, and Makoto Suematsu, and Norifumi Iijima, and Kazuhiro Kimura, and Sabrina Diano, and Chitoku Toda
January 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Ming-Liang Lee, and Hirokazu Matsunaga, and Yuki Sugiura, and Takahiro Hayasaka, and Izumi Yamamoto, and Taiga Ishimoto, and Daigo Imoto, and Makoto Suematsu, and Norifumi Iijima, and Kazuhiro Kimura, and Sabrina Diano, and Chitoku Toda
February 1999, Diabetes,
Ming-Liang Lee, and Hirokazu Matsunaga, and Yuki Sugiura, and Takahiro Hayasaka, and Izumi Yamamoto, and Taiga Ishimoto, and Daigo Imoto, and Makoto Suematsu, and Norifumi Iijima, and Kazuhiro Kimura, and Sabrina Diano, and Chitoku Toda
May 2007, PLoS medicine,
Ming-Liang Lee, and Hirokazu Matsunaga, and Yuki Sugiura, and Takahiro Hayasaka, and Izumi Yamamoto, and Taiga Ishimoto, and Daigo Imoto, and Makoto Suematsu, and Norifumi Iijima, and Kazuhiro Kimura, and Sabrina Diano, and Chitoku Toda
August 2023, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Ming-Liang Lee, and Hirokazu Matsunaga, and Yuki Sugiura, and Takahiro Hayasaka, and Izumi Yamamoto, and Taiga Ishimoto, and Daigo Imoto, and Makoto Suematsu, and Norifumi Iijima, and Kazuhiro Kimura, and Sabrina Diano, and Chitoku Toda
June 2024, Neural regeneration research,
Ming-Liang Lee, and Hirokazu Matsunaga, and Yuki Sugiura, and Takahiro Hayasaka, and Izumi Yamamoto, and Taiga Ishimoto, and Daigo Imoto, and Makoto Suematsu, and Norifumi Iijima, and Kazuhiro Kimura, and Sabrina Diano, and Chitoku Toda
May 2022, Nature metabolism,
Ming-Liang Lee, and Hirokazu Matsunaga, and Yuki Sugiura, and Takahiro Hayasaka, and Izumi Yamamoto, and Taiga Ishimoto, and Daigo Imoto, and Makoto Suematsu, and Norifumi Iijima, and Kazuhiro Kimura, and Sabrina Diano, and Chitoku Toda
February 2000, Neuroreport,
Copied contents to your clipboard!